Ariel Global Fund Added AbbVie (ABBV) on Dip
Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2024 investor letter. A ...
Le Lézard58m
AION Labs, In Continued Partnership with BioMed X, Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, and ...
PharmiWeb50m
AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity
AbbVie (NYSE: ABBV) and Gubra A/S (CPSE:GUBRA), a company specializing in preclinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases, today ...
Le Lézard57m
Dominari Securities Receives FINRA Approval to Expand Operations
Dominari Holdings Inc.  (the "Company") today announced that its wholly-owned subsidiary, Dominari Securities LLC ("Dominari"), has received approval for its Continuing Membership Application ("CMA") ...